|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2007-2-2
|
|
pubmed:abstractText |
To test whether pharmacologic angiotensin-converting enzyme (ACE) inhibition in carriers of the ACE DD or DI (D, deletion; I, insertion of 287 base pairs) genotypes can simulate the genetic advantage of the II genotype and thereby enhance the conditioning effects of aerobic exercise.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0003-9993
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
88
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
262-4
|
|
pubmed:meshHeading |
pubmed-meshheading:17270528-Anaerobic Threshold,
pubmed-meshheading:17270528-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:17270528-Exercise,
pubmed-meshheading:17270528-Exercise Tolerance,
pubmed-meshheading:17270528-Female,
pubmed-meshheading:17270528-Gene Deletion,
pubmed-meshheading:17270528-Genotype,
pubmed-meshheading:17270528-Humans,
pubmed-meshheading:17270528-Hypertension,
pubmed-meshheading:17270528-Male,
pubmed-meshheading:17270528-Middle Aged,
pubmed-meshheading:17270528-Oxygen Consumption,
pubmed-meshheading:17270528-Peptidyl-Dipeptidase A
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Do angiotensin-converting enzyme (ACE) inhibitors enhance the effect of exercise rehabilitation in patients with hypertension and ACE DD and DI genotypes?
|
|
pubmed:affiliation |
Pulmonary Institute, The Chaim Sheba Medical Center, Tel-Hashomer, Israel.
|
|
pubmed:publicationType |
Journal Article,
Controlled Clinical Trial,
Research Support, Non-U.S. Gov't
|
